{"data":{"id":"us-nm/24-2a-2","jurisdiction":"us-nm","citation":"24-2A-2","heading":"Definitions.","body":"As used in the Theodore R. Montoya Memorial Hemophilia Program Act:\nA. \"blood products\" means certain components or factors obtained from whole blood which when periodically administered to persons suffering from hemophilia result in relief or control of the disease;\nB. \"eligible patient\" means a person suffering from hemophilia whose case has been evaluated and accepted for provision of services by the hemophilia program established by the school;\nC. \"fund\" means the hemophilia fund;\nD. \"hemophilia\" means a genetic disease in which uncontrolled bleeding from otherwise minor causes may result in death or disability;\nE. \"hemophilia program\" means the New Mexico comprehensive hemophilia diagnostic and treatment program established by the school to provide comprehensive clinical evaluation of patients suffering from hemophilia, out-patient blood product usage, counseling services to families of persons suffering from hemophilia and outreach to the public;\nF. \"provider\" means any blood service or laboratory furnishing blood products to the school and its program administration for eligible patients;\nG. \"university\" means the university of New Mexico; and\nH. \"secretary\" means the secretary of health and environment [secretary of health].","path":["Chapter 24 - Health and Safety","ARTICLE 2A Hemophilia Program"],"source_url":"https://nmonesource.com/nmos/nmsa-unanno/en/item/18524/index.do","current_through":"2026-07-01","vintage":"","retrieved_at":"2026-09-03T15:02:19Z","sha256":"d83c8ed39d188e36390af5abe03ee83dfff7ed99341b56876a0b2c28b25ef86c","source_id":"us-nm","stale":false,"prev":"us-nm/24-2a-1","next":"us-nm/24-2a-3"},"notice":"GroundRules: Original legal text. Not legal advice."}